Literature DB >> 2809565

Association of ankylosing spondylitis with IgA-multiple myeloma: report of a case and pathogenetic considerations.

S M Lam, H H Ho, P Dunn, S F Luo.   

Abstract

Multiple myeloma has rarely been reported in patients with ankylosing spondylitis. We observed a patient with a 20-year history of ankylosing spondylitis, who subsequently developed IgA myeloma. This association may not be simply coincidental. It has been proposed that the protracted stimulation of immunocytes by inflammatory lesions on the mucosal surfaces of the gastrointestinal, respiratory, and biliary tracts, where lymphocytes are already committed to IgA production, may be implicated in the pathogenesis of IgA myeloma in some patients. Ankylosing spondylitis is a chronic inflammatory disease, probably resulting from the interaction of a genetic predisposition involving HLA-B27 with an environmental event such as enteric bacterial infection. We propose that ankylosing spondylitis and IgA myeloma occurring concomitantly in our patient implies a possible pathogenetic relationship. In ankylosing spondylitis, persistent reticuloendothelial stimulation, due to chronic subclinical gastrointestinal infection, may lead to IgA-producing plasma cell activation and proliferation, and subsequent IgA myeloma development.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2809565

Source DB:  PubMed          Journal:  Taiwan Yi Xue Hui Za Zhi        ISSN: 0371-7682


  4 in total

Review 1.  Ankylosing spondylitis: Chinese perspective, clinical phenotypes, and associated extra-articular systemic features.

Authors:  Huei-Huang Ho; Ji-Yih Chen
Journal:  Curr Rheumatol Rep       Date:  2013-08       Impact factor: 4.592

2.  Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.

Authors:  Linda Morris Brown; Gloria Gridley; David Check; Ola Landgren
Journal:  Blood       Date:  2008-01-31       Impact factor: 22.113

3.  Human Leukocyte Antigen-B27: The Genetic Predisposition Leading to Reactive Arthritis during Induction Phase Chemotherapy for Acute Myeloid Leukemia.

Authors:  Sandip P Bartakke; Abhilasha Ashok Sampagar; Vibha Sanjay Bafna; Putun Patel
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Jul-Sep

Review 4.  Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance.

Authors:  Alexei Shimanovsky; Juliana Alvarez Argote; Shruti Murali; Constantin A Dasanu
Journal:  BBA Clin       Date:  2016-05-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.